Pelvic Recurrence of Breast Cancer Presenting as Ovarian Carcinoma: Case Report
Roberto Angioli*, Ester Valentina Cafa, Eva Montone, Andrea Miranda, Francesca Linciano, Marta Li Destri, Paolo Gennari, Stella Capriglione and Francesco Plotti
Department of Obstetrics and Gynaecology Campus Bio Medico, University of Rome, Rome, Italy
- *Corresponding Author:
- Roberto Angioli
Department of Obstetric and Gynaecology Campus Bio Medico
University of Rome, Rome, Italy
E-mail: [email protected]
Received Date: July 08, 2013; Accepted Date: July 30, 2013; Published Date: August 04, 2013
Citation: Angioli R, Cafa EV, Montone E, Miranda A, Linciano F, et al. (2013) Pelvic Recurrence of Breast Cancer Presenting as Ovarian Carcinoma: Case Report. Chemotherapy 2:116. doi: 10.4172/2167-7700.1000116
Copyright: © 2013 Angioli R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Breast cancer is the most frequent cancer in women from western countries. The risk to develop recurrence of the tumor is about 30%. Intra-abdominal and pelvic metastases count <5% of clinical findings and they represent 30-40% and 20-40% of autopsy findings, respectively. Conventional imaging workup to follow-up of patients with breast cancer includes CT, MRI and bone scintigraphy for distant metastases.We present a rare case of a caucasian 59-years-old woman, with history of breast cancer in her anamnesis. She occurred to our attention for the onset of a single adnexal mass, ascites and increasing in waist circumference. Until then, the standard imaging tecniques were negative for relapse. Patient was affected by recurrent lobular breast cancer. Positron Emission Tomography (PET-CT) has a high sensitivity and specificity for peritoneal carcinosis and 0.5 cm is considered as a size threshold for the detection of tumor nodules. We think PET-CT could be useful in the evaluation of women suspected of distant recurrence of breast cancer. The next step should be to design prospective studies in which PET-CT will be used as first-line imaging procedure in these patients. Impact of management and survival of patient could be significant.